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ABSTRACT 
Objective: The present study aimed to investigate the possible improving effects of 17-β estradiol (EST) and genistein (GEN) on the cardiovascular 
changes associated with fructose (21% in drinking water for 8 weeks)-induced insulin resistance.  
Methods: Sham-operated and ovariectomized mature female rats were included in this study. Insulin-resistant ovariectomized animals were sc 
treated with EST (100 µg/kg) or GEN (1 mg/kg) on the daily basis for 21 consecutive days.  
Results: Induction of insulin resistance in both sham-operated and ovariectomized rats decreased the vascular responsiveness of isolated aortic 
rings towards the vasoconstrictor norepinephrine and the vasodilator acetylcholine (Ach) with no changes towards the vasodilator sodium 
nitroprusside. Fructose-induced insulin resistance was also associated with an elevation in the blood pressure (BP) with decreased serum level of 
nitric oxide (NO). Treatment of insulin-resistant ovariectomized rats with either EST or GEN improved the vascular responsiveness of isolated 
aortic rings towards Ach and succeeded to reduce the elevated BP. Moreover, both EST and GEN decreased the insulin resistance/compensatory 
hyper insulinaemia. Treatment with EST increased serum NO level.  
Conclusion: EST and GEN have the ability to improve the endothelium-dependent relaxation in insulin-resistant ovariectomized rats and modulate 
the elevated BP. 
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INTRODUCTION 
Insulin resistance and its consequent hyperinsulinemia have been 
increasing worldwide. It is a metabolic disorder that plays a role in 
the pathophysiology of many common human diseases including 
type 2 diabetes mellitus (DM), hypertension, obesity, and coronary 
heart disease [1]. It most often precedes the onset of type 2 DM by 
many years, is present in a large segment of the general population, 
and is multifactorial [2, 3]. There are convincing data to show that 
there is a genetic component associated with insulin resistance [4].  
Endothelial dysfunction and insulin resistance closely coexist and 
can be detected in the pathogenesis of atherosclerosis [5]. Several 
studies have confirmed that insulin resistance are commonly 
accompanied with endothelial dysfunction and that the exposure of 
vascular endothelium to high circulating levels of lipids and glucose 
is associated by reduced nitric oxide (NO) availability [6-8]. These 
observations have given rise to the theory that endothelial 
dysfunction is both a cause and a consequence of the metabolic 
disturbances observed in insulin resistance [9].  
The incidence of cardiovascular diseases is lower in premenopausal 
women than men of similar age, protection is lost soon after women 
reach menopause [10]. Interestingly, exogenous estrogen 
replacement therapy can decrease the incidence of myocardial 
infarction and stroke in postmenopausal women, which suggests 
that estrogen protects against dysfunction of the heart and/or blood 
vessels [11, 12]. 17-β estradiol treatment also have protective effects 
in animal models of atherosclerosis and vascular injury [10]. 
Estrogens are natural vaso protective agents due to the presence of 
ERs which have been detected in smooth-muscle cells of coronary 
arteries and endothelial cells [13].  
The present study was devoted to investigate further the possible 
protective effect of estrogens on some cardiovascular, metabolic and 
biochemical complications accompanying insulin resistance. To 
achieve this aim both sham-operated and ovariectomized rats were 
used. EST and genistein (GEN) (a phytoestrogen that is similar in 
structure and function to EST) were given subcutaneously on daily 
basis for three weeks to ovariectomized insulin-resistant animals. 
The responsiveness of the isolated aortic rings towards various 
vasoactive agents was tested. Norepinephrine was chosen as a 
vasoconstrictor agent while acetylcholine and sodium nitroprusside 
were employed as endothelium-dependent and endothelium-
independent vasodilators, respectively.  
Moreover, the blood pressure and heart rate were measured non-
invasively. For the assessment of insulin resistance-induced 
metabolic and biochemical changes, the glucose tolerance, 
hyperinsulinemia and lipid profile were investigated. Serum glucose 
levels in oral glucose tolerance test (OGTT) were taken to examine 
the glucose tolerance, the serum insulin levels were used to examine 
hyperinsulinemia and insulin resistance. Serum nitrate/nitrite level 
was also determined and used as a convenient marker for NO 
formation. 
MATERIALS AND METHODS 
Drugs and chemicals 
17-β estradiol (EST) and genistein (GEN) were purchased from 
Sigma-Aldrich (St Louis, MO, USA) and LC Laboratories (MA, USA), 
respectively. Both drugs were initially dissolved in DMSO and then 
freshly diluted in distilled water to be sc given. The concentration 
was adjusted so as to each 100 g animal body weight received 0.25 
ml, containing the required dose of either drug.  
D-Fructose was purchased from Isochem (France). Acetylcholine 
perchlorate and N-(1-Naphthyl) ethylene-diamine dihydrochloride 
(NEDD) were purchased from Sigma-Aldrich (St Louis, MO, USA). 
Norepinephrine hydrochloride, sodium nitroprusside, and 
sulphanilamide were purchased from Fluka (Italy), Oxford 
Laboratory (India), and Merck (Germany), respectively. All other 
chemicals were of the highest commercially available grade. 
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Animals 
Female albino rats, initially weighing 130-150 g, were used in this 
study. They were obtained from the Animal House Colony of the 
National Research Center (Dokki, Giza, Egypt) and were housed 
under conventional laboratory conditions throughout the period of 
experimentation. The animals were fed a standard rat pellet diet and 
allowed free access to water. The study was conducted in 
accordance with ethical procedures and has been approved by the 
National Research Center-Medical Research Ethics Committee (NRC-
MREC) for the use of animal subjects (approval number 09/110; 
date 07/2009). Rats were anaesthetized with thiopental sodium (20 
mg/kg; ip) and then ovariectomized according to the method 
described by Turner et al. (2000) [14]. Sham-operated control group 
of animals was also included. 
Induction of insulin resistance 
Three weeks after the operation, insulin resistance was induced by 
adding 21% fructose in drinking water for both ovariectomized and 
sham-operated rats for 8 weeks as described by Yadav et al. 
(2007)[15]. At the end of the 8th
16
 week, insulin resistance was 
confirmed by the oral glucose tolerance test (vide infra). Insulin-
resistant rats were those whose serum glucose level reached 140 
mg/dl or more after 30 min from the oral glucose loading dose [ ]. 
Experimental design 
While still keeping animals on fructose in drinking water, the 
effects of 3 weeks sc treatment with EST and GEN on the 
cardiovascular alterations induced by insulin-resistance were 
assessed. Two sets of experiments were carried out. In each set the 
following 6 groups (8-12 rats each) were used:  
Group I: sham-operated rats 
Group II: ovariectomized rats 
Group III: sham-operated rats with insulin resistance 
Group IV: ovariectomized rats with insulin resistance 
Group V: ovariectomized rats with insulin resistance treated with 
EST (100 μg/kg/day) [17, 18] 
Group VI: ovariectomized rats with insulin resistance treated with 
GEN (1 mg/kg/day) [19] 
The first set of experiments was used for systolic blood pressure 
(BP), heart rate and vascular reactivity assessment while the second 
set of experiments was used for the biochemical determinations. The 
aforementioned parameters of the two sets of experiments were 
assessed 24 h after the administration of the last dose of either EST 
or GEN. 
Blood pressure and heart rate measurements 
Systolic blood pressure and heart rate of animals were indirectly 
measured by non-invasive BP monitor (ML 125 NIBP, AD 
Instruments, Australia) from the tail of conscious rats by the tail-cuff 
technique for which all animals were pre-trained until BP was 
steadily recorded with minimal stress and restraint. In the tail-cuff 
technique, animals were warmed for 30 min at 28 °C in a 
thermostatically controlled heating cabinet (Ugo Basille, Italy) for 
better detection of tail artery pulse, the tail was passed through a 
miniaturized cuff and a tail-cuff sensor that was connected to an 
amplifier (ML 125 NIBP, AD Instruments, Australia). The amplified 
pulse was recorded during automatic deflation of the cuff. Systolic 
BP was defined as the cuff inflation pressure at which waveform 
become indistinguishable from the baseline noise. The average of at 
least 5 measurements was taken at each occasion. Heart rate was 
recorded automatically by a counter triggered by the pulse wave. 
The Chart for windows (v 7) software was used to record and 
elaborate data. 
Assessment of vascular reactivity 
The vascular reactivity towards NE as a vasoconstrictor, Ach as an 
endothelium-dependent vasodilator, and SNP as an endothelium-
independent vasodilator was assessed using the isolated aortic ring 
preparation described by Cocks et al. (1988) [20]. Briefly, segments 
of thoracic aortas were rapidly excised from cervical dislocated 
animals. They were placed in warm Krebs’ solution and dissected 
free of surrounding tissue before being cut into transverse rings of 
3-5 mm length. An aortic ring was mounted in 10 ml water jacketed 
automatic multi-chamber organ bath system (Model no. 
ML870B6/C, Panlab, Spain) containing Krebs’ solution of the 
following composition (g/l): NaCl 6.9, KCl 0.35, KH2PO4 0.16, 
MgSO4 .7H2O 0.3, CaCl2.2H2O 0.37, NaHCO3 2.1, and glucose 1.05. 
The organ bath solution was continuously aerated with carbogen (a 
mixture of 95% O2  and 5% CO2) and its temperature was kept at 
37oC. The mounted aortic ring was suspended horizontally between 
2 hooks passed through its lumen, care being taken not to injure the 
luminal surface. The bottom hook was attached to a support leg 
while the upper one was attached to a force-displacement 
transducer (Model no. MLT0201, Panlab, Spain) connected to an 
amplifier (Power Lab, Ad Instruments Pty. Ltd.) which is connected 
to a computer. The chart for windows (v 3.4) software was used to 
record and elaborate data. The preparation was allowed to 
equilibrate for about 2 h under a resting tension of 2 g during that 
time any change in the resting tension was readjusted. 
NE, Ach, and SNP were freshly prepared by dissolving them in Kerbs’ 
solution. Serial dilutions of each vasoactive agent were prepared 
such that cumulative additions to the bath gave a final bath 
concentration ranging from 10-9M to 10-4M. For testing the relaxant 
effects of Ach or SNP, pre-contraction with NE was carried out first 
with a concentration that produce approximately 60-70% of the 
maximum contractile response. Contractile responses to NE were 
expressed as percentage of maximal response while relaxant 
responses to the vasodilators Ach and SNP were expressed as 
percentage relaxation of the pre-contraction value. 
Assessment of biochemical parameters 
Blood samples were withdrawn from the retro-orbital venous plexus 
of 18 h food-deprived rats. Collected blood samples were allowed to 
stand for 10 min at room temperature then centrifuged at 4o
After blood sampling from 18 h food-deprived animals (zero time), 
each animal received a glucose loading dose of 1 ml/100 g of body 
weight from a 50% w/v glucose solution by oral gavage. Thereafter, 
blood samples were again withdrawn at 30, 60, and 120 min (
C using 
cooling centrifuge (Laborezentrifugen, 2 k 15, Sigma, Germany) at 
3000 xg for 10 min and sera were separated for the assessment of 
the following biochemical parameters. 
Oral glucose tolerance test 
16). 
Serum glucose level was determined as quinineamine using a test 
reagent kit (Stanbio, USA) according to the method of Trinder 
(1969) [21]. The absorbance was measured at 510 nm and the 
results were expressed as mg/dl. A curve was obtained after 
determining serum glucose level after zero, 30, 60, 120 min for the 6 
groups from which the area under the curve (AUC) was calculated 
for each group using the trapezoidal rule. 
Determination of insulin level 
Serum insulin level was adopted by the method described by 
Judzewitsch et al. (1982) [22] using solid phase enzyme-linked 
immunosorbent assay (ELISA) method using a test reagent kit 
(Labor Diagnostika Nord, Nordhorn, Germany). The absorbance of 
the samples and the standard solutions were measured at 450 nm 
using ELISA reader (ELx800, Ultra Microplate Reader BIO-TEK 
Instruments Inc., USA) against blank and the results were expressed 
as μIU/ml. 
Determination of homeostatic model assessment-insulin 
resistance index 
Insulin sensitivity was determined by HOMA-IR index which was 
calculated for all groups using the following equation [23] 
 
*Constant used when glucose is in mg/dl 
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Determination of nitric oxide level 
The total amount of NO was indirectly estimated in terms of its main 
metabolites, nitrate and nitrite by the Griess reaction using NEDD and 
sulphanilamide as described by Miranda et al. (2001) [24] after 
deproteinizing the seum samples with absolute ethanol. The absorbance 
was measured at 540 nm and the results were expressed as nmol/ml. 
Statistical analysis 
Data are expressed as means±SEM. Statistical significance was taken 
as p<0.05 for all experiments, using one way analysis of variance 
(ANOVA) followed by Tukey’s multiple comparisons test to judge the 
difference between various groups for the parametric parameters. 
For the non-parametric parameters Kruskal-Wallis non-parametric 
ANOVA followed by Dunn’s multiple comparisons test was used. 
Graph Pad Prism software (version 5.00 for Windows, San Diego, 
California, USA) was used to carry out all statistical tests. 
RESULTS 
Effects of EST and GEN on blood pressure and heart rate 
Induction of insulin resistance with fructose (21% in drinking water 
for 11 weeks) was associated with an elevation in the BP and a 
reduction in the heart rate of both sham-operated and 
ovariectomized rats. Treatment of insulin-resistant ovariectomized 
rats with either EST (100 µg/kg/day; sc) or GEN (1 mg/kg/day; sc) 
for 21 consecutive days succeeded to normalize the elevated BP 
values which was associated with elevations in the reduced heart 
rate reaching about 87% and 75% of the normal value, respectively 
(table 1). 
 
Table 1: Effects of 17-β estradiol and genistein on systolic blood pressure, heart rate, and serum nitric oxide level of insulin-resistant 
ovairectomized rats 
Groups BP (mm/Hg) HR (bpm) NO (µM) 
Normal-fed rats Sham-operated 93.37±4.59 319.77±18.56 63.20±3.70 
Ovx 106.77±1.60 314.13±18.75 61.95±5.72 
Insulin resistant 
rats 
Sham-operated 109.96*±1.43 217.35*±16.10 38.94*±2.36 
Ovx 129.70*@±11.87 191.51*±18.96  34.66*±1.10 
Ovx+EST 94.78†±5.40 278.94†±16.88 52.78†±5.08 
Ovx+GEN 88.47†±3.55 239.89†±23.13 33.76±3.40 
Three weeks after ovariectomization, rats were rendered insulin-resistant by giving fructose (21%) in drinking water for 8 weeks. EST (100 µg/kg/day) 
and GEN (1 mg/kg/day) were s. c. injected for 3 weeks while still keeping animals on fructose in drinking water. Twenty-four hours after the last dose of 
either drug, BP and HR were measured non-invasively and blood samples from 18 h food-deprived animals were withdrawn and serum NO level was 
measured. 
 
Insulin resistance was confirmed by oral glucose tolerance test and 
insulin-resistant rats were those whose serum glucose level reached 
140 mg/dl or more after 30 min from the oral glucose loading dose. 
Results are expressed as means±SEM (n=6-10). 
Statistical analysis was carried out by ANOVA followed by Tukey’s 
multiple comparisons test. 
* Significant difference from corresponding normal rats at p<0.05. 
@ Significant difference from insulin-resistant sham-operated 
control at p<0.05. 
† Significant difference from insulin-resistant ovariectomized 
control at p<0.05. 
Effects of EST and GEN on the vascular reactivity of isolated 
aortic rings 
Effect of EST and GEN on NE-induced contractions 
Addition of cumulative concentrations of NE, starting from 10-9 M to 10-4 
M, to aortic rings isolated from either sham-operated or ovariectomized 
rats resulted in concentration-dependent contractions. A maximum 
tension was developed at 1×10-5 M NE and 1×10-4
Addition of cumulative concentrations of Ach, starting from 10
 M NE, respectively. 
 There was a marked decrease in the vascular responsiveness of aortic 
rings isolated from insulin-resistant sham operated and ovariectomized 
rats towards various concentrations of NE as compared to that isolated 
their corresponding controls. Treatment of insulin-resistant 
ovariectomized rats with either EST (100 µg/kg/day; sc) or GEN (1 
mg/kg/day; sc) for 21 consecutive days decreased the vascular 
responsiveness of isolated aortic rings towards lower concentrations of 
NE as compared to the respective insulin-resistant ovariectomized 
untreated group (fig. 1a). 
Effect of EST and GEN on Ach-induced relaxations 
-9 M to 
10-4 M, to aortic rings isolated from either sham-operated or 
ovariectomized rats and subjected to pre-contraction with 10-6 M of 
NE, elicited a dose-dependent relaxation. A maximum relaxation 
reached about 87% and 75% of the pre-contracted value, 
respectively. There was a marked decrease in the vascular 
responsiveness of aortic rings isolated from insulin-resistant sham 
operated and ovariectomized rats towards almost all concentrations 
of Ach as compared to that isolated from their corresponding 
controls. Treatment of insulin-resistant ovariectomized rats with 
EST (100 µg/kg/day; sc) for 21 consecutive days succeeded to 
reverse the attenuated vascular responsiveness of isolated aortic 
rings towards almost all concentrations of Ach. Similar treatment of 
insulin-resistant ovariectomized rats with GEN (1 mg/kg/day; sc) 
showed a tendency to increase the vascular responsiveness of 
isolated aortic rings towards Ach as compared to the respective 
insulin-resistant ovariectomized untreated group(fig. 1b). 
Effect of EST and GEN on SNP-induced relaxations 
Addition of cumulative concentrations of SNP, starting from 10-9 M to 10-4 
M, to aortic rings isolated from either sham-operated or ovariectomized 
rats and subjected to pre-contraction with 10-6 M of NE, produced a 
dose-dependent relaxation. A maximum relaxation reached about 139% 
and 164% of the pre-contracted value, respectively. There was no 
significant change in the vascular responsiveness of aortic rings isolated 
from insulin-resistant sham operated rats towards almost all 
concentrations of SNP as compared to that isolated from its 
corresponding control. On the other hand, there was a decrease in the 
vascular responsiveness of aortic rings isolated from insulin-resistant 
ovariectomized rats towards lower concentrations of SNP as compared 
to that isolated from its corresponding control.  
The responsiveness was, however, increased at high concentrations 
of SNP starting from 1×10-6
Three weeks after ovariectomization, rats were rendered insulin-
resistant by giving fructose (21%) in drinking water for 8 weeks. 
EST (100 µg/kg/day) and GEN (1 mg/kg/day) were s. c. injected for 
3 weeks while still keeping on fructose in drinking water. Twenty-
four hours after the last dose of either drug, aortas were isolated and 
suspended as rings (length, 3-5 mm). Relaxation was induced by 
applying cumulative concentrations of Ach (b) and SNP (b) on aortic 
rings precontraced with 10
 M. Treatment of insulin-resistant 
ovariectomized rats with either EST (100 µg/kg/day; sc) or GEN (1 
mg/kg/day; sc) for 21 consecutive days tended to normalize the 
decreased vascular responsiveness of isolated aortic rings towards 
various concentrations of SNP (fig. 1c). 
-6 M of NE. 
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Fig. 1: Effects of 17-β estradiol and genistein on NE-induced contraction (a), Ach (b) and SNP (c)-induced relaxations of aortic rings 
isolated from insulin-resistant ovariectomized rats 
 
Insulin resistance was confirmed by oral glucose tolerance test and 
insulin-resistant rats were those whose serum glucose level reached 
140 mg/dl or more after 30 min from the oral glucose loading dose. 
Results are expressed as means±SEM (n=6-10). 
Statistical analysis was carried out by ANOVA followed by Turkey’s 
multiple comparisons test. 
* Significant difference from corresponding normal rats at p<0.05. 
@
Adding 21 % fructose to drinking water of sham-operated and 
ovariectomized rats for 11 weeks produced an elevation in serum 
glucose level in OGTT as compared to its corresponding controls. 
This elevation appears to be prominent throughout the whole 
experiment and showed an elevation in the AUC of the OGTT in both 
sham-operated and ovariectomized rats (fig. 2). Additionally, a 
profound elevation in serum insulin level leading to an elevation in 
the HOMA-IR index was also demonstrated (fig. 3). Insulin-resistant 
animal model was also associated with a decrease in serum NO level 
as compared to its corresponding control (table 1). 
Treatment of insulin-resistant ovariectomized rats with either 
EST (100 µg/kg/day; sc) or GEN (1 mg/kg/day; sc) for 21 
consecutive days showed a decrease in serum insulin level as 
compared to the respective insulin-resistant ovariectomized 
untreated group. Similar treatment with either EST (100 
µg/kg/day; sc) or GEN (1 mg/kg/day; sc) succeeded to decrease 
the HOMA-IR index (fig. 3), with no change in serum glucose 
level in OGTT as compared to the respective insulin-resistant 
ovariectomized untreated group (fig. 2). 
Treatment of insulin-resistant ovariectomized rats with EST (100 
µg/kg/day; sc) for 21 consecutive days caused an elevation in serum 
NO level. On the other hand, similar treatment of insulin-resistant 
ovariectomized rats with GEN (1 mg/kg/day; sc) showed no change 
in serum NO level (table 1).  
Insulin resistance was confirmed by oral glucose tolerance test and 
insulin-resistant rats were those whose serum glucose level reached 
140 mg/dl or more after 30 min from the oral glucose loading dose. 
Results are expressed as means±SEM (n=6-10). 
Statistical analysis was carried out by ANOVA followed by Tukey’s 
multiple comparisons test. 
 Significant difference from insulin-resistant sham-operated 
control at p<0.05. 
† Significant difference from insulin-resistant ovariectomized 
control at p<0.05. 
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Fig. 2: Effects of 17-β estradiol and genistein on oral glucose 
tolerance test (a) and its area under the curve (b) in insulin-
resistance ovariectomized rats 
Three weeks after ovariectomization, rats were rendered insulin-
resistant by giving fructose (21%) in drinking water for 8 weeks. 
EST (100 µg/kg/day) and GEN (1 mg/kg/day) were s. c. Injected for 
3 weeks while still keeping animals on fructose in drinking water. 
Twenty-four hours after the last dose of either drug, 18 h food-
deprived animals were given a glucose loading dose (1 ml/100 g of 
body weight from a 50 % w/v glucose solution) and serum glucose 
levels were determined at 0, 30, 60, and 120 min post loading. 
 
DISCUSSION 
The present study provided further evidence that FRT-fed animal model, 
a common method used for induction of insulin resistance, was 
accompanied by some cardiovascular alterations. These cardiovascular 
changes were evidenced as hypertension and alterations in the reactivity 
of isolated aortic rings towards a vasoconstrictor, as well as 
endothelium-dependent and independent vasodilators 
It has been documented that FRT induces insulin resistance/ 
compensatory hyperinsulinemia, and hypertension [25-29] where 
insulin resistance precedes hypertension [27, 30]. Several 
mechanisms have been proposed to mediate the link between 
insulin resistance/compensatory hyperinsulinemia and 
hypertension, including the continuous activation of the sympathetic 
nervous system [31], increased production and/or activity of 
vasoconstrictors, such as angiotensin II [32], endothelin-1 [33], and 
thromboxane A2 (28), as well as impaired endothelium-dependent 
relaxation [34]. Oxidative stress and abnormal NO activity have been 
proposed to be a link for the development of hypertension [35]. In 
addition, oxidative stress has been linked to a decrease in NO 
availability. Each of these proposed mechanisms can contribute to 
an increase in the vascular tone, which can lead to the development 
of endothelial dysfunction and eventually the development of 
hypertension [30]. Impaired endothelium-dependent vasodilation is 
considered to be the hallmark of endothelial dysfunction, which is 
mediated by NO. A defect in NO production and/or activity has been 
proposed as a main mechanism of endothelial dysfunction and a 
contributor to atherosclerosis [36].  
In this study, it has been found that there was a marked decrease in 
the vascular responsiveness of aortic rings isolated from FRT-
induced insulin resistant sham operated and ovariectomized rats 
towards Ach as compared to normal sham-operated rats. This is 
consistent with previous observations that revealed that 
endothelium-dependent relaxation response to Ach is impaired in 
FRT-induced insulin resistant rats [31, 37, 38] and in insulin 
resistant mice [39].  
Treatment of FRT-induced insulin resistant ovariectomized rats 
with either EST or GEN for three weeks succeeded to reverse the 
attenuated vascular responsiveness of isolated aortic rings towards 
Ach and to ameliorate the FRT-induced hypertension. These results 
were consistent with other studies which showed that EST has an 
important role in the regulation of vascular function. EST enhances 
Ach-induced endothelium-dependent relaxation in the guinea pig 
coronaries [40] and in rat aorta without changing the vascular 
responses to Ach in endothelium-denuded aortic rings isolated from 
prepubertal female rats [41]. 
It has been proposed that the improved endothelium-dependent 
vasodilation towards Ach after EST treatment is due to an 
upregulation of NOS III protein expression with a subsequent 
increase in NO availability [40, 42].  
Moreover, it has been documented that the role of vascular ERs is 
very important in modulating the vascular tone. Both ERα and ERβ 
subtypes have been demonstrated to mediate the vasodilator effects 
of EST in CVS.  
These effects are mediated by genomic as well as nongenomic 
mechanisms some of which include increases in local NO [43]. 
Nongenomic activation of eNOS by estrogens via ERα has been 
reported in endothelial cells of different vascular bed such as 
pulmonary artery and bovine aorta. This response is rapid, mediated 
via genomic effects and also occurs in low concentrations, hence 
influences the vascular tone at physiological concentration [44]. 
Moreover, the antioxidant property of EST also may attribute to the 
restored endothelial function [45].  
The phytoestrogen, GEN, potentiated endothelium-dependent 
vasodilatation and enhances coronary vascular reactivity in 
atherosclerotic female monkeys [46] and is able to act as estrogen 
agonist on ER of the vascular wall [47]. It has been observed that 
GEN in vitro may induce an endothelium-dependent vasodilatation 
in mesenteric bed on NE-preconstricted vessels through COX 
pathway in a dose-dependent manner [48]. GEN can stimulate PGI 2
49
 
synthesis in cultured human umbilical vein endothelial cells via ER-
dependent mechanism which has the ability to enhance the COX-2 
activity [ ]. Chronic oral GEN administration improved endothelial 
function in male spontaneously hypertensive rats by reducing the 
vascular O2-• 50 production [ ]. It has also been suggested that GEN 
induced relaxant effect is probably due to inhibition of voltage-
dependent Ca2+ 51channels [ ].  
Previous studies concerned with the contractile response of α1-
adrenoceptor agonists showed, however, inconsistent results, while 
in some increased reactivity was demonstrated [52, 53], in others 
decreased [54] or unchanged responsiveness (38) was shown. This 
discrepancy could be due to difference in the amount and duration 
of fructose consumption [30].  
In the present study, treatment of FRT-induced insulin resistant 
ovariectomized rats with either EST or GEN for three weeks 
decreased the vascular responsiveness towards NE as compared to 
the respective insulin resistant ovariectomized untreated group. 
This result was consistent with other studies which showed a 
significant decrease in contractile response of rat tail artery towards 
NE, after intravenous injection of EST [55]. Pretreatment with EST 
also decreased contractile responses towards NE in the tail artery 
[56]. The inhibitory effect of EST on the pressor responses to NE 
may be related to its modulation of VSMC intracellular free Ca2+ 
through its actions on membrane Ca2+ 55channels [ ]. 
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Also, studies had shown that GEN could decrease the contractile 
responses towards different vasoconstrictors viz. KCI, 5-HT and 
CaCl2 19 in isolated porcine coronary arteries [ ]. This may be 
attributed to its inhibitory effect to tyrosine kinase which plays an 
important role in mediating the responses associated with an 
intracellular Ca2+ 57release [ ].  
In the present study, the effect on endothelium-independent 
relaxation induced by SNP on FRT-treated rats was also assessed. 
SNP exerts its direct vaso relaxant effect on the vascular smooth 
muscle cells via spontaneous release of NO, without the involvement 
of vascular endothelium [58]. There was no change in the vascular 
responsiveness of aortic rings isolated from hyperglycemic rats 
towards various concentrations of SNP. This result confirms 
previous reports indicating that insulin resistance does not 
significantly influence endothelium-independent vasodilation by 
SNP [38, 59, 60]. It releases NO independent of NOS and acts directly 
on guanylate cyclase in the smooth muscle [61]. Treatment of insulin 
resistant ovariectomized rats with EST or GEN for three weeks 
showed no significance change in the vascular responsiveness 
towards SNP as compared to either normal rats or insulin resistant 
rats. This result is consistent with previous studies that showed that 
the relaxation response of thoracic aorta rings to SNP after EST 
treatment had no significant difference among the groups (62). GEN 
has a direct effect on the aortic smooth muscle [19]. 
CONCLUSION 
Finally, one can conclude from all the previously mentioned findings 
that estrogens namely, EST (the natural occurring estrogen) and 
GEN (a phytoestrogen) have a beneficial and protective effect 
against the vascular dysfunction associated with insulin resistance. 
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